Hecolin

HEV-239 recombinant vaccine · Xiamen Innovax Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Hecolin, covering 2016-05-18 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children [Phase 2]